RISEDRONATE SODIUM MONOHYDRATE
UNII F67L43UT5C

Substance Identification & Data

This profile provides standardized clinical and technical data for Risedronate Sodium Monohydrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F67L43UT5C.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 353228-19-0 and the RxNorm Concept ID (RxCUI) 1356128. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

F67L43UT5C

CAS Registry Number

353228-19-0

RxNorm Concept ID

1356128

Detailed Substance Profile

Preferred Name

RISEDRONATE SODIUM MONOHYDRATE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

F67L43UT5C

The specific atomic composition represented as a molecular structure string.

InChIKey

C7H10NO7P2.Na.H2O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

KLQNARDFMJRXSF-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C218269

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

23709605

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(Cc1cccnc1)(P(=O)(O)[O-])(P(=O)(O)O)O.[Na+].O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Risedronate Sodium Monohydrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.